MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.74
+1.09 (5.03%)
At close: Dec 11, 2024, 4:00 PM
22.70
-0.04 (-0.18%)
After-hours: Dec 11, 2024, 5:11 PM EST

MBX Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Net Income
-55.18-32.56-26.14
Depreciation & Amortization
0.230.160.06
Loss (Gain) From Sale of Assets
0.070.07-
Loss (Gain) From Sale of Investments
-2.13-1.04-0.03
Stock-Based Compensation
4.752.040.31
Other Operating Activities
0.10.11.39
Change in Accounts Payable
2.970.410.67
Change in Other Net Operating Assets
-0.6-1.150.62
Operating Cash Flow
-49.79-31.98-23.12
Capital Expenditures
-0.84-0.13-0.44
Investment in Securities
-121.37-30.8-10.97
Investing Cash Flow
-122.21-30.93-11.41
Short-Term Debt Issued
--10
Total Debt Issued
--10
Net Debt Issued (Repaid)
--10
Issuance of Common Stock
174.770.740.03
Other Financing Activities
-4.01-0.03-0.46
Financing Cash Flow
234.2669.2246.06
Net Cash Flow
62.266.3111.53
Free Cash Flow
-50.63-32.11-23.56
Free Cash Flow Per Share
-3.68-2.62-2.94
Levered Free Cash Flow
--20.56-
Unlevered Free Cash Flow
--20.56-
Change in Net Working Capital
-0.56-
Source: S&P Capital IQ. Standard template. Financial Sources.